HomeBlog

 

Title: Neuroanatomical Variability and Substance Use Initiation in Late Childhood and Early Adolescence
Authors:  Alex P. Miller, PhD, David A. A. Baranger, PhD, Sarah E. Paul, MA, Hugh Garavan, PhD, Scott Mackey, PhD, Susan F. Tapert, PhD, Kimberly H. LeBlanc, PhD, Arpana Agrawal, PhD, Ryan Bogdan, PhD
Year:  2025
Journal:  JAMA Network Open

 

Introduction 
Some studies have reported differences in brain structure in teens who use cannabis compared to those who do not. The question is: does cannabis cause such brain changes? Or did they exist before cannabis initiation, maybe signaling a vulnerability to drug use? This study looked at whether differences in the brains of teens who start using drugs, including  cannabis are there from the beginning or if they develop because of drug use. Here we focus on the authors’ results specific to cannabis.
  
Methods 
 The researchers used data from the Adolescent Brain Cognitive Development (ABCD) Study, which tracked 9,804 kids aged 9–11 over several years. Each year, the kids reported if they had started using drugs, including cannabis. At the start, brain scans measured features like the size and thickness of certain brain areas. The team used advanced statistical methods to identify links between brain structure and cannabis use, while accounting for other factors like exposure to substances before birth. 
  
Results 
The study found that kids who started using cannabis had smaller right caudate volumes (a part of the brain involved in learning and memory, emotional regulation, response to rewards, as well as planning and execution of movement). Importantly, this was already true before they started using cannabis, suggesting that having a smaller right caudate might make some teens more likely to try cannabis, rather than cannabis use causing the brain change. 

Discussion 
These results  challenge the idea that all brain changes associated with cannabis use are caused by the substance itself. Instead, some differences might be developmental and make certain teens more likely to use cannabis or other drugs. More long-term studies are needed to better understand how brain differences and cannabis use are connected. 

Read the full study here.

Citation: Miller AP, Baranger DAA, Paul SE, et al. Neuroanatomical Variability and Substance Use Initiation in Late Childhood and Early Adolescence. JAMA Netw Open. 2024;7(12):e2452027. doi:10.1001/jamanetworkopen.2024.52027

Dr. Alex Miller, the first author of this study, presented at the CMCR Investigator’s Meeting on January 23, 2025. His presentation provides additional insights into this study and can be viewed below.

Exploring the Entourage:
The Therapeutic Potential of Minor Cannabinoids, Terpenes, and Flavonoids

 

The Center for Medicinal Cannabis Research (CMCR) hosted a virtual, two-day symposium on October 12-13, 2023 highlighting the state of science in medicinal cannabis research. Whereas the majority of current research focuses on delta-9-THC and cannabidiol, the 2023 CMCR Symposium highlighted emerging clinical and translational research on the "other" constituents of cannabis (minor cannabinoids, terpenes, and flavonoids) and the entourage effect.

 

2023 CMCR Symposium Awards

Thirty years of Human Cannabinoid Administration Studies Contributing to the Development of Medical Cannabinoids
Marilyn Huestis, AB, MS, PhD, Professor; Senior Fellow at Thomas Jefferson University; Science & Policy Advisor at Pinney Associates; President of Huestis & Smith Toxicology, LLC

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies
Margaret Haney, PhD, Professor of Neurobiology (in Psychiatry) at Columbia University Irving Medical Center, New York State Psychiatric Research Center

Moderated panel discussion and Q&A with 2023 CMCR Symposium Award Recipients

Videos of congratulations from 2022 Award Recipients - Video from Dr. Daniele Piomelli and Video from Dr. Donald Abrams

 

CMCR Special Lectures

A Randomized Clinical Trial of Cannabidiol for Behavioral Problems in Boys with Severe Autism
Doris Trauner, MD, Distinguished Professor Emerita of Neurosciences at UC San Diego

A Double-Blind Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality
Marcel Bonn-Miller, PhD, Chief Scientific Officer, Charlotte's Web

 

Panel 1: Update on Federal activities affecting cannabis research moderated by Steve Gust, PhD, Advisor to CMCR

Moderated discussion with panelists

Panelists:
David Shurtleff, PhD, Deputy Director, National Center for Complementary and Integrative Health
Cassandra Taylor, PhD, Botanical Products, Center for Drug Evaluation and Research, US Food and Drug Administration
Richard (Rik) Kline, PhD, Chief, Chemistry and Pharmaceutics Branch, NIDA


 

The Entourage: Minor Cannabinoids, Terpenes, and Flavonoids

Assessing the Analgesic and Subjective Effects of Inhaled Beta-Caryophyllene Alone and with Delta-9 THC in healthy volunteers
Ziva Cooper, PhD, Professor of Psychiatry and Biobehavioral Sciences and Anesthesiology at UCLA

Behavioral Pharmacology of D-Limonene and THC
Ryan Vandrey, PhD, Professor at the Johns Hopkins University Behavioral Pharmacology Research Unit (BPRU)

Anti-allodynic effects of Beta-caryophyllene in rodent models of neuropathic pain
Sara Jane Ward, PhD, Associate Professor of Neural Sciences, Lewis Katz School of Medicine, Temple University

Anti-seizure and Entourage Effects of Plant Cannabinoids in Preclinical Models
Jonathan C. Arnold, PhD, Deputy Academic Direct of The Lambert Initiative for Cannabinoid Therapeutics, Professor of Cannabinoid Pharmacology at the University of Sydney

Terpenes from Cannabis Sativa are Cannabimimetic and Selectively Enhance Cannabinoid Activity
John Streicher, PhD, Professor of Pharmacology at the University of Arizona

Q&A Discussion moderated by Drs. Ziva Cooper and Patrick Still

 

Panel 2: Use of minor cannabinoids, terpenes, and flavonoids in the community moderated by Igor Grant, MD

Moderated discussion with panelists
Panelists:
Dale Gieringer, PhD, California NORML
Bonni Goldstein, MD, Medical Director, CannaCenters
Michelle Sexton, ND, Medical Staff Professional, Center for Integrative Medicine, UC San Diego
Sherry Yafai, MD, Medical Director, The ReLeaf Institute

 

The State of Cannabis: A Survey of 5,000 Californians
Linda Hill, MD, MPH, Distinguished Professor in the Department of Surgery, School of Medicine, Assistant Dean at the School of Public Health, UC San Diego

Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis
Tom Marcotte, PhD, CMCR Co-Director, Professor of Psychiatry, UC San Diego

 

Poster Session videos


 

Free CME is available for the 2023 CMCR Symposium. Click here to view the activity and claim CME.

LINK to CMCR Symposia Series

November 1, 2023, Eric Rasmussen of KSTP-TV in Minneapolis referred to CMCR's recent JAMA Psychiatry article about field sobriety testing and impaired driving. Minnesota, where recreational cannabis became legal this summer, is looking at how Colorado is enforcing DWI laws. Read the full article here.

David Ovalle and Laurie McGinley, Washington Post, August 30, 2023. Dr. Igor Grant spoke to the Washington Post regarding the US Department Health and Human Services recommendation and the implications of rescheduling marijuana from Schedule I to Schedule III. Read the full article here.

Dr. Tom Marcotte and colleagues recently published their findings in JAMA Psychiatry of a double-blind, placebo-controlled, parallel randomized clinical trial that evaluated 184 cannabis users on aspects of field sobriety testing (FST) used by law enforcement as a tool to detect cannabis impairment. The study found that more specific roadside testing of cannabis-impaired drivers is needed.

Click HERE to read the full article in JAMA Psychiatry

Click HERE to read JAMA Psychiatry's Editorial of this article

Click HERE to read UC San Diego's article "Can Field Sobriety Tests Identify Drivers Under the Influence of Cannabis?"

Click HERE to read CBS8's article "Study: Field Sobriety Tests are Inadequate at Identifying Drivers Under the Influence of Cannabis"

Click HERE to read City News Service's article "Study: Field Sobriety Tests are Insufficient for DUI Cases Involving THC"